Osteoblast as a target of anti-osteoporotic treatment.

about

Epigallocatechin-3-Gallate Ameliorates Glucocorticoid-Induced Osteoporosis of Rats in Vivo and in Vitro.

P2860

Q55031617-1542D489-3637-4250-A69A-9873238B5E7F

P2860

Osteoblast as a target of anti-osteoporotic treatment.

Item

http://www.wikidata.org/entity/Q47996918

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Osteoblast as a target of anti-osteoporotic treatment.

@en

Osteoblast as a target of anti-osteoporotic treatment.

@nl

type

Item

label

Osteoblast as a target of anti-osteoporotic treatment.

@en

Osteoblast as a target of anti-osteoporotic treatment.

@nl

prefLabel

Osteoblast as a target of anti-osteoporotic treatment.

@en

Osteoblast as a target of anti-osteoporotic treatment.

@nl

P1476

Osteoblast as a target of anti-osteoporotic treatment.

@en

P2093

Addolorata Corrado

http://www.w3.org/2001/XMLSchema#string

Eliana Rita Sanpaolo

http://www.w3.org/2001/XMLSchema#string

Francesco Paolo Cantatore

http://www.w3.org/2001/XMLSchema#string

Silvana Di Bello

http://www.w3.org/2001/XMLSchema#string

P2860

In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment

The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation

Lrp5 functions in bone to regulate bone mass

Extracellular modulators of Wnt signalling

Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism

High bone mass in mice expressing a mutant LRP5 gene

A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis

Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes

P304

858-865

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00325481.2017.1362312

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28770650

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

osteoblast

Osteoblast as a target of anti-osteoporotic treatment.

about

P2860

P2860

Osteoblast as a target of anti-osteoporotic treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921